Ureteral stent

• US 8,021,434 B2
• Filed: 02/03/2005
• Issued: 09/20/2011
• Est. Priority Date: 03/07/2002
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Segura, Joseph, Teague, James
• Primary Examiner(s): Sweet; Thomas J
• Assistant Examiner(s): Prone; Christopher D
• Application Number:
  US11/048,772
• Publication Number:
  US 20050131547A1
• Time in Patent Office: 2,420 Days
• Field of Search: 623/23.7, 623 2364- 2367, 623/26.64, 623/23.68, 623/23.72, 606 29- 30, 604/8, 604/9
• US Class Current: 623/23.7
• CPC Class Codes: A61F 2002/048 Ureters
• CPC Class Codes: A61M 2210/1082 Kidney
• CPC Class Codes: A61M 2210/1085 Bladder
• CPC Class Codes: A61M 2210/1089 Urethra
• CPC Class Codes: A61M 27/002 Implant devices for drainage of body fluids from one part of the body to another intraocular A61F9/00781; middle ear A61F11/202
• CPC Class Codes: A61M 27/008 pre-shaped, for use in the urethral or ureteral tract

Abstract

A stent is designed to be placed within a patient'"'"'s ureter to facilitate drainage from the patient'"'"'s kidneys to the bladder. An elongated portion of the stent includes a length sufficient to extend substantially within the ureter from the kidney to the bladder, and defines a lumen extending therethrough. A first end portion extends from one end of the elongated portion and is adapted to assume a retaining configuration when placed substantially within the kidney. A second end portion extends from another end of the elongated portion and flares outward when placed substantially within the bladder to maintain position. The second end portion allows fluids to flow through the lumen and into the bladder and is collapsible to prevent fluid from passing from the bladder to the kidney.

Claims

1. A ureteral stent, comprising:

(a) an elongated portion defining a lumen extending therethrough and including a length sufficient to extend substantially within the ureter from the kidney to the bladder;

(b) a first end portion extending from one end of the elongated portion, defining an interior space in communication with the lumen, and defining at least one opening in communication with the interior space, the first end portion for placement substantially within the kidney and adapted to assume a retaining configuration when placed substantially within the kidney; and

(c) a second end portion extending from another end of the elongated portion and flaring outward when placed substantially within the bladder to maintain position substantially within the bladder, the second end portion including a single continuous sheet forming a conical wrapping, the conical wrapping being self-collapsible after implantation to at least partially prevent fluid from passing into the lumen from the bladder, the second end portion remaining proximal of the elongated portion when disposed within the bladder.

2. The ureteral stent of claim 1, wherein the second end portion includes a tail configured to transport liquid into the bladder.

3. A ureteral stent for facilitating drainage from the kidney to the bladder, the ureteral stent comprising:

(a) an elongated portion defining a lumen extending therethrough and including a length sufficient to extend substantially within the ureter from the kidney to the bladder;

(b) a first end portion extending from one end of the elongated portion, defining an interior space in communication with the lumen, and defining at least one opening in communication with the interior space, the first end portion for placement substantially within the kidney and adapted to assume a retaining configuration when placed substantially within the kidney; and

(c) a second end portion extending from another end of the elongated portion and including a sheet wrapped such that a first side of the sheet is adjacent a second side of the sheet to form a conical structure, the second end portion adapted for placement, and for maintaining position, substantially within the bladder, the conical structure having a first end, a second end having a width greater than a width of the first end, and a wrapped segment disposed between the first and second ends, the wrapped segment including at least one and a half windings, the sheet defining a lumen configured to fluidically couple the lumen defined by the elongated portion with the bladder when in a first configuration, the sheet being self-collapsible into a second configuration such that the elongated portion is substantially fluidically isolated from the bladder when in the second configuration.

4. The stent according to claim 3 wherein the second end portion comprises a polymer.

5. The stent of claim 3 wherein the second end portion comprises one or more tails for transporting liquid into the bladder.

6. The ureteral stent of claim 3, wherein the second end portion is self-collapsible.

7. The ureteral stent of claim 3, wherein the second end portion is self-collapsible, the second end portion remaining proximal the elongated portion when disposed within the bladder.

8. The ureteral stent of claim 3, wherein the sheet is solid such that a liquid cannot pass through the sheet.

9. The stent of claim 3, wherein the second end portion comprises a super-elastic material.

10. The stent of claim 9, wherein the super elastic-material comprises a nickel-titanium alloy.

11. The stent of claim 3, wherein the second end portion comprises a mesh.

12. A ureteral stent comprising:

an elongated portion defining a lumen extending therethrough and including a length sufficient to extend substantially within the ureter from the kidney to the bladder;

a first end portion extending from one end of the elongated portion, the first end portion configured to be placed substantially within the kidney and adapted to assume a retaining configuration when placed substantially within the kidney; and

a second end portion extending from another end of the elongated portion, the second end portion including a single continuous sheet wrapped to form a conical structure, the conical structure being self-collapsible after implantation to at least partially prevent fluid from passing into the lumen of the elongated member from the bladder, the second end portion configured to be placed substantially within the bladder, the second end portion including a tail disposed within the conical structure and configured to transport liquid into the bladder.

13. The ureteral stent of claim 12, wherein the tail extends from an inner surface of the second end portion to a location beyond an end of the second end portion.

14. The ureteral stent of claim 12, wherein the tail is attached to the proximal end of the elongated member.

15. The ureteral stent of claim 12, wherein the tail is attached proximate to the first end portion of the elongated member such that a portion of the tail is disposed within the lumen of the elongated member.

16. The ureteral stent of claim 12, wherein the tail is configured to transport liquid by capillary action through the conical structure to the bladder.

17. The ureteral stent of claim 12, wherein the first end portion defines an interior space in communication with the lumen, the first end portion defines at least one opening in communication with the interior space.

18. The ureteral stent of claim 12, wherein the second end portion comprises a super-elastic material.

19. The ureteral stent of claim 18, wherein the super elastic-material comprises a nickel-titanium alloy.

20. The ureteral stent of claim 12, wherein the second end portion comprises a mesh.